Browse by Tags

Are Generic Drugs taking business away from big Pharma?

I was reading another blog, and realized Comedy Central now has their own site with videos and ran across this classic from the Today Show. With all the recent discussions on how big Pharma spends money and recent marketing techniques, here it is...

Published Thu, Sep 09 2008 10:45 PM by The Medical Quack

Filed under: Need a Laugh, drugs, Pharma, Generic Drugs, Marketing, Comdey

How to Create a Blockbuster - Are there 50 ways?

Interesting correlation on how the move business and Pharma share similar business plans when it comes to producing a blockbuster drug. R and D, yup, got high costs with both, unpredictable, yup, nobody knows until the release, budgets and flops...

Published Thu, Sep 09 2008 10:59 AM by The Medical Quack

Filed under: Pharma/FDA News, Other Items of Interest, personalized medicine, drugs, healthcare, Pharma, blockbusters

Viagra - The Game?

Yes you heard it right, there's an online advertising spot that will grant access to the game, you can perhaps find it on Forbes and other online publications, and you also get to listen to "Viva Viagra" while you play. So who's...

Published Thu, Sep 09 2008 10:29 AM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, My Commentaries, Pharma, Viagra, Pfizer, Advertising, erectile dysfunction

Japanese Drug Industry Makes Another Billion-Dollar U.S. Buy

More big fish, small fish in the Pharma business, this time a 3rd Japanese firm buying a US Company. Are there going to be many left here in the US, Pfizer we love you. BD Shionogi, is buying Sciele Pharma, a small, publicly traded...

Published Tue, Sep 09 2008 7:01 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, Pharma, Buy Outs, Japan

Gilead may shoot past big firms' buyout hunts

All over healthcare the big fish, little fish story is either taking place or actions are in the making for offers. There certainly are a number of big Pharma companies with money to foot the bill, that is if the Biotech companies see it fit to...

Published Tue, Sep 09 2008 2:34 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Pharma, Biotech, Genentech, Amgen, Stocks, Gliead, Buy Outs

Johnson & Johnson Gets Rejected - Doribax

Well back to the drawing board to gather up some additional data. We live in a world of data today, overloaded data for that matter, and decisions just are not as simple as they used to be. With all the additional side effects coming to light...

Published Fri, Aug 08 2008 12:39 AM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, Pharma, FDA, Johnson and Johnson

Medco Health, FDA To Study Genetic Testing For Medications

More additional affiliations for the FDA to gather information. In the news recently have been other agreements with companies such as Blue Cross and others who will be providing data to also study the effects of drugs through medical record information...

Published Mon, Aug 08 2008 11:34 PM by The Medical Quack

Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, health insurance, healthcare IT, Pharma, Biotech, FDA, Medco, Pharmacogonomics

Merck Vioxx study was for marketing - ADVANTAGE by name..

The meaning of advantage is below. Who knows what might be uncovered next as this may or may not be just a Merck issue, but as documents and other items of years past surface, this is what we have, sell, sell, sell, and it's perhaps not unlikely...

Published Mon, Aug 08 2008 11:12 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, Pharma, Marketing, Merck, Vioxx, Clinical Study

States Say no to pre-emption for Drug Legal Suits

Does this say that the FDA is perhaps not as trusted as we might like the agency to be? On the other hand is it possible to entrust any agency to this level today, and that might be more to the point. There are so many areas that need to come...

Published Fri, Aug 08 2008 12:13 PM by The Medical Quack

Filed under: Medically Related, Technology, Pharma, FDA, Congress, Legal Suits, Drugmakers

Patients Fear Their Rapport With Genentech Is in Danger

Right now according to the Wall Street Journal, patients who have enjoyed an open relationship are worried that this could all change under management from Roche. Is bigger always better? Recently in the news Genentech is not happy with the...

Published Thu, Aug 08 2008 1:05 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Pharma, Biotech, Cancer, clinical trials, Genentech, Rocha

Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR(R)

As marketing intensity increases, there are some strange bedfellows emerging and who knows what could be the next affiliation we may read about? Ask your Abbott representative about Crestor. BD Under the terms of the agreement, Abbott...

Published Thu, Aug 08 2008 12:04 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Pharma, Abbott, Lipitor, AstraZenaca, Crestor, Lipids

CVS Goes for Longs - Another Step in Drugstore Consolidation

One reason stated is convenience, more on every corner, like the gas stations. To take advantage of some of the other low cost benefits, there may be a longer driving distance. A while back I had a conversation with someone from CVS, and there...

Published Wed, Aug 08 2008 1:20 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Pharma, Prescriptions, Pharmacies, CVS, Longs Drugs

Pharma sales to physicians: emotions beat evidence

Some things in sales don't change no matter what field you are in and Pharma is no different, sales are made by building relationships, in other words, people do business with people they like, so the peer articles maybe could be just a little off...

Published Wed, Aug 08 2008 12:59 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, My Commentaries, Physicians, Pharma, Sales

Sanofi-Aventis Sues Apotex Over Taxotere US Patents

The patent is stated not to expire until 2010 and this will put a 30 hold at the FDA to grant approval. This one should prove interesting to follow and see where the infringement occurs. BD LONDON -(Dow Jones)- Sanofi-Aventis SA (SNY) has...

Published Tue, Aug 08 2008 11:34 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, Lawsuit, Pharma, Cancer, FDA, Patents

BIO Chief on the Wisdom of Giving Money to Democrats and a few other matters

Discussed here is the recent law in Massachusetts relative to gifts, etc. just recently passed. Being the CEO of BIO, the biotech industry trade group, of course there's an interest in not having funds diminished, but also addresses the interest...

Published Tue, Aug 08 2008 2:21 PM by The Medical Quack

Filed under: Medically Related, Technology, Pharma/FDA News, Pharma, Biotech, Congress, Politics, Lobbying, Contributions

Syndication

Recent Posts

Tags

Archives